Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€5.34
30.05.23
-
30.05.24
14.61%
24.07.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Fortuna Silver Mines Inc.

Start price
Target price
Perf. (%)
€3.02
30.05.23
-
30.05.24
5.00%
17.07.23

Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected
Fortuna Silver Mines Inc.

Start price
Target price
Perf. (%)
€3.60
16.04.23
-
16.04.24
-16.11%
30.05.23

Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.87
24.03.23
-
24.03.24
12.58%
18.05.23

Could be very worthwhile Investment >20% year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.55
03.01.23
-
03.01.24
78.44%
14.05.23

Could be worthwhile Investment >10% per year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€25.86
27.10.21
€40.00
31.12.23
-59.32%
08.05.23

Could be very worthwhile Investment >20% year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.49
10.10.21
€5.00
31.12.23
-32.83%
08.05.23

Could be very worthwhile Investment >20% year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.46
04.01.23
€12.00
31.12.25
63.49%
05.05.23

Could be very worthwhile Investment >20% year
Canadian Solar Inc.

Start price
Target price
Perf. (%)
€36.73
11.03.23
€30.00
11.03.24
0.48%
18.04.23

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.79
20.09.21
-
20.09.25
-26.16%
03.04.23

Could be worthwhile Investment >10% per year
buy
Canadian Solar Inc.

Start price
Target price
Perf. (%)
€26.85
14.03.22
€40.00
14.03.23
36.78%
11.03.23

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Fortuna Silver Mines Inc.

Start price
Target price
Perf. (%)
€3.32
14.11.22
-
14.11.23
-8.52%
24.02.23

Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected
First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€10.10
21.02.22
-
21.02.23
-35.47%
22.02.23

Could be very worthwhile Investment >20% year
buy
New Gold Inc.

Start price
Target price
Perf. (%)
€1.51
08.02.22
€1.85
08.02.23
-35.14%
09.02.23

Could be worthwhile Investment >10% per year
Capable Management
Future proof or reliable business model
buy
Nexgen Energy Ltd

Start price
Target price
Perf. (%)
€3.69
05.02.22
€6.00
05.02.23
12.57%
06.02.23

Could be worthwhile Investment >10% per year
Fair valuation
positive Cash Flow expected
Mag Silver Corp.

Start price
Target price
Perf. (%)
€12.89
17.10.22
-
17.10.23
-2.21%
30.01.23

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€0.98
14.12.21
-
14.12.22
-39.08%
15.12.22

Could be worthwhile Investment >10% per year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€4.85
01.12.21
-
01.12.22
-53.67%
02.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.05
20.09.22
€1.80
20.09.23
36.59%
19.11.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
buy
Mag Silver Corp.

Start price
Target price
Perf. (%)
€18.19
06.11.21
-
06.11.22
-21.41%
07.11.22

buy
Fortuna Silver Mines Inc.

Start price
Target price
Perf. (%)
€4.46
06.11.21
-
06.11.22
-34.65%
07.11.22

Top 10 in its market
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Capable Management
buy
Fortuna Silver Mines Inc.

Start price
Target price
Perf. (%)
€2.41
23.08.22
-
23.08.23
21.54%
01.11.22

Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected
buy
Mag Silver Corp.

Start price
Target price
Perf. (%)
€17.26
30.10.21
-
18.01.25
-25.35%
17.10.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.39
03.08.22
€2.80
03.08.23
-14.19%
20.09.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
buy
First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€8.29
09.08.22
-
09.09.22
-3.35%
10.09.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Capable Management
Future proof or reliable business model